Response To: Correspondence on “Associations of Baseline Use of Biologic or Targeted Synthetic Dmards with Covid-19 Severity in Rheumatoid Arthritis” by Sparks Et Al
AuthID
P-00Y-DXC
P-00Y-DXC
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service